CAS 942063-28-7

General Information

Perampanel, a first-in-class substance (a non-competitive AMPA receptor antagonist), is used to treat patients with epilepsy aged 12 and older. Specifically, it is used as adjunctive therapy for partial onset seizures (with or without secondarily generalized seizures) and primary generalized tonic-clonic (PGTC) seizures.

About the API

Technology Synthetic
Therapeutic category Neurology-Psychiatry
Available formulations Oral Liquid Oral Solid
Regulations US DMF Flag US DMF